Company / Assets per Share
Xeris Biopharma Holdings, Inc. Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$2.57
FY2025
5-year range
$2.34 / $7.14
FY2021-FY2025
Trend
+9.7%
vs FY2024
Sector context
#180 of 210
Health Care
What the data says
Xeris Biopharma Holdings, Inc.'s assets per share of $2.57 is lower than 86% of companies in the Health Care sector (FY2025). Assets per Share returned to growth in FY2025 after 3 years of decline, reaching $2.57.
Based on SEC 10-K filings.
2.57 in FY2025 with a 5-year CAGR of -7.2%.
Improved from $2.37 to $2.57 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -2.4%
- 5-Year CAGR
- -7.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 210This company $2.57 Sector average $353.15
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 9.7% year-over-year.
- Ranks #180 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2021.
- Lowest assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.57 | +9.7% |
| FY2024 | $2.34 | -1.2% |
| FY2023 | $2.37 | -14.2% |
| FY2022 | $2.76 | -61.3% |
| FY2021 | $7.14 | +91.2% |
| FY2020 | $3.73 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026